COO · Cooper Companies Inc

NASDAQ Health Care Large Cap Clavix B-
57.88−0.06  (−0.10%)

Price

Snapshot

50 fields · last close
Market Cap$11.02B
P/E19.32
Float193.8M
Beta0.82
Volatility20.6%
ExchangeNASDAQ
SectorHealth Care
Cap tierLarge cap
Macro sensitivityModerate
Clavix score71.1
Price57.88
Change−0.10%
Prev Close57.94
Open58.00
Day Low57.37
Day High58.25
Avg Vol4
Avg $ Vol$218.0M
52W High89.83
52W Low51.01
52W Pos17.7%
From High−35.57%
From Low+13.47%
Max DD 1Y−36.82%
Spread0.10%
LiquidityNormal
SMA 20+3.61%
SMA 50−8.92%
SMA 200−17.25%
RSI (14)50.3
Vol 30D56.6%
Vol 90D39.6%
1Y Range51–90
Daily bars537
Perf Week+6.57%
Perf Month+7.75%
Perf Quarter−19.07%
Perf Half Y−16.59%
Perf Year−19.03%
Perf YTD−28.64%
Prev Day−0.10%
ClavixB-
Debt / Eq0.30
Curr Ratio1.89
Int Cover5.8×
FCF Margin10.6%
Rev Growth+5.1%
ProfitProfitable
LeverageLow
Sector rank40 / 49

What COO does

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.

The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia.

Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage.

This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing.

The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers.

The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Clavix risk grade

regraded every trading day
B-71.1/100

COO grades B-, 71.1 of 100. Steadiest on Macro Resilience (66), most exposed on Sector Resilience (55, mixed). 0 of the 4 weighted dimensions sit above the Health Care median. Ranks 40 of 49 in Health Care by Clavix score.

PriceMacroSectorNewsFinancial

How rough the ride is

COOHealth Care median
Betavs the overall market · lower is steadier0.820.84
Volatilityannualized20.6%20.9%
Max drawdown, past yearworst peak-to-trough fall−36.8%—
Typical daily movemedian absolute daily change0.95%—
Days beyond ±3%of the last 252 sessions21 (8%)—

How its days are spread

Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.

52-week range

COO
57.94

The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.

Drawdown from the 1-year peak

COO

Percent below the running high over the last 12 months. Zero is a fresh high.

Market sensitivity

COOHealth Care median
Beta to the markethow much it swings with the S&P 500 · lower is safer0.820.84
Macro sensitivityrate, dollar and credit exposure bucketModerateModerate 53% of 49

Where it sits on the macro scale

Low 12Moderate 26High 8Very High 3

Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.

Where it ranks in its sector

Sector
Health Care49 companies ranked
COO
#40 of 49

Rank by Clavix score within the sector. Right is the top of the sector.

Price performance

COO
1 week+6.6%
1 month+7.7%
Year to date−28.6%
1 year−19.0%

Context for the rank, not itself a risk measure.

Recent coverage, scored

COO
Articles scoredthe most recent scored coverage, up to 3030 since 26 Sep
Average score0 most bearish, 100 most bullish28
Bullish · bearisharticles above 60 · below 404 · 25
Directionarticles whose tone is improving vs worsening4 ↑ 25 ↓

Where the article scores land

Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.

Balance sheet, against the sector

Debt / equityTotal debt vs shareholder equity · lower is stronger
0.30sector median 0.65 · 49 names
Current ratioShort-term assets vs liabilities · higher is stronger
1.89sector median 1.69 · 49 names
FCF marginFree cash flow as a share of revenue · higher is stronger
10.6%sector median 10.6% · 49 names
Interest coverageOperating income vs interest expense · higher is stronger
5.8×sector median 6.3× · 44 names

The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.

Growth

COO
Revenue growthyear over year+5.1%

Financial Health is shown but does not count toward the grade. Why

0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.

Recent news

most recent scored articles · the chip is the article’s score · click to open

The Rosen Law Firm is investigating potential securities claims against Cooper Companies on behalf of shareholders, based on allegations the company may have released materially misleading business information. Shareholders who purchased COO stock may be eligible to seek compensation through a contingency fee arrangement, meaning they pay no upfront legal fees.

Source PRNewsWire Significance major Impact regulatory Risk worsening

Read the article →

Rosen Law Firm announced it is investigating potential securities claims against The Cooper Companies (COO) on behalf of shareholders, based on allegations that the company may have issued materially misleading business information to investors. Shareholders who purchased COO securities may be entitled to compensation through a no-upfront-cost arrangement.

Source Newsfile Corp Significance major Impact regulatory Risk worsening

Read the article →

Rosen Law Firm announced it is investigating potential securities claims against The Cooper Companies (COO) on behalf of shareholders, alleging the company may have issued materially misleading business information. Investors who bought CooperCompanies securities may be entitled to compensation through a contingency fee arrangement, meaning no upfront legal costs.

Source Newsfile Corp Significance major Impact regulatory Risk worsening

Read the article →

Rosen Law Firm, an investor rights law firm, announced it is investigating potential securities claims against Cooper Companies on behalf of shareholders, alleging the company may have released misleading business information to investors. Shareholders who bought COO securities may be eligible to seek compensation with no upfront legal fees.

Source Newsfile Corp Significance major Impact regulatory Risk worsening

Read the article →

Rosen Law Firm announced it is investigating potential securities claims on behalf of Cooper Companies (COO) shareholders, alleging the company may have issued materially misleading business information to investors. Shareholders who purchased CooperCompanies securities may be entitled to compensation through a contingency fee arrangement.

Source PRNewsWire Significance major Impact regulatory Risk worsening

Read the article →

Nearest peers by size

Health Care
TickerCompanyGradeMkt capP/EBeta
UHSUniversal Health Services IncA-$10.91B7.151.11Compare
MOHMolina Healthcare IncB$10.82B22.930.73Compare
ALGNAlign Technology IncB$10.46B25.301.74Compare
GMEDGlobus Medical IncB$10.30B19.240.97Compare
DVADaVita IncB$11.95B14.100.87Compare
BTSGBrightspring Health Services IncB-$12.04B32.911.88Compare
PODDInsulet CorpB-$9.79B26.071.08Compare
GKOSGlaukos CorpB$9.72B—0.73Compare

You just read one holding. Clavix reads the whole portfolio.

Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.